Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos
Autor(a) principal: | |
---|---|
Data de Publicação: | 2019 |
Tipo de documento: | Trabalho de conclusão de curso |
Idioma: | por |
Título da fonte: | Repositório Institucional da UFS |
Texto Completo: | http://ri.ufs.br/jspui/handle/riufs/15778 |
Resumo: | Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated. |
id |
UFS-2_1eb89b5fc7f31a56e6593cfc57d259c9 |
---|---|
oai_identifier_str |
oai:ufs.br:riufs/15778 |
network_acronym_str |
UFS-2 |
network_name_str |
Repositório Institucional da UFS |
repository_id_str |
|
spelling |
Silva, Wallace Marcelo AlmeidaCipolotti, Rosana2022-05-26T12:20:51Z2022-05-26T12:20:51Z2019-02-27SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019.http://ri.ufs.br/jspui/handle/riufs/15778Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated.Objectivo: Caracterizar as manifestações oculares (OM) de pacientes pediátricos que tratam de linfoblastos agudos leucemia (ALL) e para avaliar se estão associados a factores de risco preditivos bem descritos de recaída, protocolo (1999 ou 2009), género e infiltração do líquido cefalorraquidiano. Métodos: Foi realizado um estudo de coorte prospectivo em crianças e adolescentes com TODOS, de Janeiro de 2013 a Dezembro de 2017. Os pacientes foram submetidos a avaliações oftalmológicas antes de iniciar o tratamento (D0), no oitavo dia (D8), ao 28º dia (D28), e aos seis meses (D6 meses). A hipertensão ocular (OH) foi considerada em resultados acima dos 21 mmHg. As medidas de acuidade visual < 20/40 foram consideradas perda visual (VL). Resultados: Cinquenta e cinco pacientes foram examinados e 18 (32,7%) apresentaram OM, foram OH (61,1%), hemorragia da retina (22,2%) e VL (22,2%) os achados mais frequentes. Foi encontrada uma forte associação entre doentes com OM e aqueles com elevado risco de recaída (p = 0,035, Cramer V = 0,31) e que utilizaram o protocolo de 1999 (p = 0,022, Cramer V = 0,32). O risco de OM nos doentes do protocolo de 1999 era de 2,917 (CI = 1,099-7,742), enquanto que o risco de recaída foi de 0,327 (IC 95% 0,107-0,999). Conclusões: Os doentes com TODOS têm uma elevada incidência de OM devido ao tratamento e à própria doença, e podem até ser assintomáticos e evoluir com a VL. Destes, podemos destacar OH como o mais prevalecente. Pacientes submetidas ao protocolo de 1999 e com elevado risco de recaída são mais susceptíveis de apresentar OM e estas variáveis são fortemente associado.AracajuporLeucemia linfoblástica agudaGlaucomaEsteróidesQuimioterapiaAcute lymphoblastic leukemiaGlaucomaSteroidsChemotherapyCIENCIAS DA SAUDE::MEDICINAManifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anosinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/bachelorThesisUniversidade Federal de SergipeDME - Departamento de Medicina – Aracaju - Presencialreponame:Repositório Institucional da UFSinstname:Universidade Federal de Sergipe (UFS)instacron:UFSinfo:eu-repo/semantics/openAccessLICENSElicense.txtlicense.txttext/plain; charset=utf-81475https://ri.ufs.br/jspui/bitstream/riufs/15778/1/license.txt098cbbf65c2c15e1fb2e49c5d306a44cMD51ORIGINALWallace_Marcelo_Almeida_Silva.pdfWallace_Marcelo_Almeida_Silva.pdfapplication/pdf656148https://ri.ufs.br/jspui/bitstream/riufs/15778/2/Wallace_Marcelo_Almeida_Silva.pdf9a7e1edc5e57bef253e2642241164827MD52TEXTWallace_Marcelo_Almeida_Silva.pdf.txtWallace_Marcelo_Almeida_Silva.pdf.txtExtracted texttext/plain104531https://ri.ufs.br/jspui/bitstream/riufs/15778/3/Wallace_Marcelo_Almeida_Silva.pdf.txt9a7f550d17d193435fe2da608745ce0aMD53THUMBNAILWallace_Marcelo_Almeida_Silva.pdf.jpgWallace_Marcelo_Almeida_Silva.pdf.jpgGenerated Thumbnailimage/jpeg1277https://ri.ufs.br/jspui/bitstream/riufs/15778/4/Wallace_Marcelo_Almeida_Silva.pdf.jpgf3a92d60969827afb4f150fc7926fc9eMD54riufs/157782022-05-26 09:20:52.146oai:ufs.br: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Repositório InstitucionalPUBhttps://ri.ufs.br/oai/requestrepositorio@academico.ufs.bropendoar:2022-05-26T12:20:52Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS)false |
dc.title.pt_BR.fl_str_mv |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
title |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
spellingShingle |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos Silva, Wallace Marcelo Almeida Leucemia linfoblástica aguda Glaucoma Esteróides Quimioterapia Acute lymphoblastic leukemia Glaucoma Steroids Chemotherapy CIENCIAS DA SAUDE::MEDICINA |
title_short |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
title_full |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
title_fullStr |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
title_full_unstemmed |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
title_sort |
Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos |
author |
Silva, Wallace Marcelo Almeida |
author_facet |
Silva, Wallace Marcelo Almeida |
author_role |
author |
dc.contributor.author.fl_str_mv |
Silva, Wallace Marcelo Almeida |
dc.contributor.advisor1.fl_str_mv |
Cipolotti, Rosana |
contributor_str_mv |
Cipolotti, Rosana |
dc.subject.por.fl_str_mv |
Leucemia linfoblástica aguda Glaucoma Esteróides Quimioterapia |
topic |
Leucemia linfoblástica aguda Glaucoma Esteróides Quimioterapia Acute lymphoblastic leukemia Glaucoma Steroids Chemotherapy CIENCIAS DA SAUDE::MEDICINA |
dc.subject.eng.fl_str_mv |
Acute lymphoblastic leukemia Glaucoma Steroids Chemotherapy |
dc.subject.cnpq.fl_str_mv |
CIENCIAS DA SAUDE::MEDICINA |
description |
Objective: To characterize ocular manifestations (OM) of pediatric patients treating for acute lymphoblastic leukemia (ALL) and to evaluate whether they are associated with well-described predictive risk factors for relapse, protocol (1999 or 2009), gender and cerebrospinal fluid infiltration. Methods: A prospective cohort study was conducted in children and adolescents with ALL from January 2013 to December 2017. The patients underwent ophthalmologic evaluations before starting treatment (D0), on the eighth day (D8), at the 28th day (D28), and at six months (D6 months). Ocular hypertension (OH) was considered in results above 21 mmHg. Measures of visual acuity < 20/40 were considered visual loss (VL). Results: Fifty-five patients were examined and 18 (32.7%) presented OM, been OH (61.1%), retinal hemorrhage (22.2%) and VL (22.2%) the most frequent finds. A strong association was found between patients with OM and those with a high risk of relapse (p = 0.035, Cramer V = 0.31) and who used the 1999 protocol (p = 0.022, Cramer V = 0.32). The risk of OM in patients from the 1999 protocol was 2.917 (CI = 1.099–7.742), while the risk of relapse it was 0.327 (CI 95% 0.107–0.999). Conclusions: Patients with ALL have a high incidence of OM due to the treatment and the disease itself, and it may even be asymptomatic and evolve with VL. Of these, we can highlight OH as the most prevalent. Patients submitted to the 1999 protocol and at high risk of relapse are more likely to present OM and these variables are strongly associated. |
publishDate |
2019 |
dc.date.issued.fl_str_mv |
2019-02-27 |
dc.date.accessioned.fl_str_mv |
2022-05-26T12:20:51Z |
dc.date.available.fl_str_mv |
2022-05-26T12:20:51Z |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/bachelorThesis |
format |
bachelorThesis |
status_str |
publishedVersion |
dc.identifier.citation.fl_str_mv |
SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019. |
dc.identifier.uri.fl_str_mv |
http://ri.ufs.br/jspui/handle/riufs/15778 |
identifier_str_mv |
SILVA,Wallace Marcelo Almeida. Manifestações oculares em pacientes pediátricos com leucemia linfoblástica aguda: uma coorte de cinco anos. 2019. 48 f. Monografia (Graduação em Medicina) - Centro de Ciências Biológicas e da Saúde, Departamento de Medicina, Universidade Federal de Sergipe, Aracaju, 2019. |
url |
http://ri.ufs.br/jspui/handle/riufs/15778 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.publisher.initials.fl_str_mv |
Universidade Federal de Sergipe |
dc.publisher.department.fl_str_mv |
DME - Departamento de Medicina – Aracaju - Presencial |
dc.source.none.fl_str_mv |
reponame:Repositório Institucional da UFS instname:Universidade Federal de Sergipe (UFS) instacron:UFS |
instname_str |
Universidade Federal de Sergipe (UFS) |
instacron_str |
UFS |
institution |
UFS |
reponame_str |
Repositório Institucional da UFS |
collection |
Repositório Institucional da UFS |
bitstream.url.fl_str_mv |
https://ri.ufs.br/jspui/bitstream/riufs/15778/1/license.txt https://ri.ufs.br/jspui/bitstream/riufs/15778/2/Wallace_Marcelo_Almeida_Silva.pdf https://ri.ufs.br/jspui/bitstream/riufs/15778/3/Wallace_Marcelo_Almeida_Silva.pdf.txt https://ri.ufs.br/jspui/bitstream/riufs/15778/4/Wallace_Marcelo_Almeida_Silva.pdf.jpg |
bitstream.checksum.fl_str_mv |
098cbbf65c2c15e1fb2e49c5d306a44c 9a7e1edc5e57bef253e2642241164827 9a7f550d17d193435fe2da608745ce0a f3a92d60969827afb4f150fc7926fc9e |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositório Institucional da UFS - Universidade Federal de Sergipe (UFS) |
repository.mail.fl_str_mv |
repositorio@academico.ufs.br |
_version_ |
1802110810057605120 |